Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorDuran, Mesut Berkan
dc.contributor.authorYıldırım, Ömer
dc.contributor.authorKızılkan, Yalçın
dc.contributor.authorTosun, Çağatay
dc.contributor.authorÇırakoğlu, Abdullah
dc.contributor.authorGültekin, Mehmet Hamza
dc.contributor.authorGül, Ümit
dc.contributor.authorAltan, Mesut
dc.contributor.authorOngün, Şakir
dc.date.accessioned2022-08-19T06:39:55Z
dc.date.available2022-08-19T06:39:55Z
dc.date.issued2021en_US
dc.identifier.issn2050-1161
dc.identifier.urihttps://doi.org/10.1016/j.esxm.2020.100292
dc.identifier.urihttps://hdl.handle.net/20.500.12462/12462
dc.descriptionOngun, Şakir (Balikesir Author)en_US
dc.description.abstractIntroduction: Coronavirus disease 2019 (COVID-19) pandemic caused unprecedented restrictions in outpatient services and surgical practices in urology as in other medical branches as well as in all areas of life. Aim: To investigate whether there have been variations in the presentations of male patients with sexual and reproductive health problems to the outpatient urology clinics during the COVID-19 pandemic and to understand the underlying factors for these variations, if any. Methods: Male patients aged >= 18 years who presented to the outpatient urology clinics in 12 centers across Turkey from February 1, 2020 to June 1, 2020 were retrospectively evaluated. The patients were divided into 2 groups: those who presented to the outpatient clinic from February 1, 2020 to March 11, 2020 comprised the "pre-COVID-19 pandemic period" group, whereas those who presented to the outpatient clinic from March 12, 2020 to June 1, 2020 comprised the "COVID-19 pandemic period" group and compared with each other. Main Outcome Measures: The main outcome of this study was the number and diagnose of patients presented to urology outpatient clinics. Results: Andrological problems were detected in 721 of 4,955 male patients included in the study. During the COVID-19 pandemic period, there was a significant increase in andrological diagnosis in these patients compared with the pre-COVID-19 pandemic period (n = 293 [17%] vs n = 428 [13.2%], P < .001, respectively). Similarly, there was a statistically significant increase in the number of patients diagnosed with male reproductive or sexual health problems during the COVID-19 pandemic period (n = 107 [6.2%] vs n = 149 [4.6%], P = .016 and n = 186 [10.8%] vs n = 279 [8.6%], P = .013, respectively). The number of patients diagnosed with erectile dysfunction during the pandemic was also significantly higher than the pre-COVID-19 pandemic period (n = 150 [8.7%] vs n = 214 [6.6%], P = .008). Conclusion: Presentations to the outpatient urology clinics owing to andrological problems markedly increased during the pandemic period. Although these problems are of multifactorial origin, psychogenic factors are also considered to significantly trigger these problems. Copyright (C) 2020, The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.en_US
dc.language.isoengen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.isversionof10.1016/j.esxm.2020.100292en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAndrologyen_US
dc.subjectCOVID-19en_US
dc.subjectErectile Dysfunctionen_US
dc.subjectMale Sexual Healthen_US
dc.subjectMale Reproductive Healthen_US
dc.subjectPandemicen_US
dc.titleVariations in the number of patients presenting with andrological problems during the coronavirus disease 2019 pandemic and the possible reasons for these variations: A multicenter studyen_US
dc.typearticleen_US
dc.relation.journalSexual Medicineen_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorID0000-0002-8253-4086en_US
dc.identifier.volume9en_US
dc.identifier.issue1en_US
dc.identifier.startpage1en_US
dc.identifier.endpage7en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster